EconPapers    
Economics at your fingertips  
 

New biomarkers of inflammation in hospitalized patients with atrial fibrillation

Caballero, Turro Mesa and Del Río Mesa

Health Leadership and Quality of Life, 2023, vol. 2, 202

Abstract: INTRODUCTION: Atrial fibrillation (AF) is the most common sustained arrhythmia worldwide, with a strong clinical association with heart failure. International literature has revealed new hematological and biomolecular markers of inflammation and oxidative stress not explored in our setting. OBJECTIVE: To relate new biomolecular and hematological markers of inflammation with clinical, epidemiological and echocardiographic characteristics of hospitalized patients with atrial fibrillation METHOD: An observational, descriptive and cross-sectional study was carried out in patients with atrial fibrillation admitted to the cardiology service of the “Saturnino Lora” Provincial Teaching Hospital in Santiago de Cuba, during the period from January 2019 to January 2020. The relationship between selected clinical, sociodemographic, electro and echocardiographic variables with hematological and biomolecular inflammatory markers was established RESULTS: patients ≥ 65 years old, female sex, combined risk factors, mainly arterial hypertension and diabetes mellitus predominated; there was a statistically significant association between the neutrophil/lymphocyte ratio and the appearance of complications, stroke, altered renal function, but not with the type of atrial fibrillation; Interesting relationships were also found between the total leukocyte and lymphocyte count, platelet/lymphocyte ratio and selected clinical variables. CONCLUSIONS: Hematological and biomolecular markers of inflammation in patients with atrial fibrillation are related to clinical evolution, appearance of complications and could be useful for stratifying the risk of complications.

Date: 2023
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:dbk:health:v:2:y:2023:i::p:202:id:202

DOI: 10.56294/hl2023202

Access Statistics for this article

More articles in Health Leadership and Quality of Life from AG Editor
Bibliographic data for series maintained by Javier Gonzalez-Argote ().

 
Page updated 2025-09-21
Handle: RePEc:dbk:health:v:2:y:2023:i::p:202:id:202